Walleye Capital’s Wave Life Sciences WVE Stock Holding History

Walleye Capital’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$275K	Buy	47,300 +19,200	+68%	+$127K	﹤0.01%	3241
2026 Q1	$204K	Buy	28,100 +22,000	+361%	+$287K	﹤0.01%	3337
2025 Q4	$104K	Sell	6,100 -12,800	-68%	-$130K	﹤0.01%	3854
2025 Q3	$138K	Sell	18,900 -300	-2%	-$2.43K	﹤0.01%	3542
2025 Q2	$125K	Buy	19,200 +18,600	+3,100%	+$123K	﹤0.01%	3663
2025 Q1	$4.85K	Buy	+600	New	+$6.56K	﹤0.01%	4106
2019 Q3	–	Sell	-22,600	Closed	-$590K	–	2313
2019 Q2	$590K	Buy	+22,600	New	+$634K	0.06%	433

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Walleye Capital's WVE Position: Q2 2026 in Review

Walleye Capital increased its Wave Life Sciences (WVE) stake by 19% in Q2 2026, buying an estimated $610K and bringing the position to 585,453 shares worth $3.4M. The position accounts for 0.01% of the portfolio, ranked #1083.

Walleye Capital first reported a position in WVE in Q3 2020 and has held it in 16 quarters since. The position peaked at $6.52M in Q4 2024. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

Walleye Capital held 585,453 shares of Wave Life Sciences worth $3.4M as of Q2 2026.
Walleye Capital bought 91,941 Wave Life Sciences shares in Q2 2026, an estimated $610K.
Wave Life Sciences made up 0.01% of Walleye Capital's portfolio in Q2 2026, its #1083 holding.
Walleye Capital first reported a position in Wave Life Sciences in Q3 2020 and has held it in 16 quarters since.
Walleye Capital's Wave Life Sciences position peaked at $6.52M in Q4 2024.
239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.